KBI Biopharma, Inc. Releases Inaugural FIH Manufacturing Batch at Integrated Switzerland Facility
Products
KBI Biopharma, Inc. a JSR Life Sciences company, has announced that successfully released its inaugural First In Human (FIH) manufacturing batch in compliance with current Good Manufacturing Practice (cGMP) standards in its recently expanded Geneva mammalian cell manufacturing facility.
For details, please see the announcement from JSR Life Sciences LLC on URL.